DavidPerlmutterMD · 2025-02-10 · David Perlmutter (host), Austin Perlmutter
Is Lifting Weights the Best Dementia Prevention? Muscle’s Impact on Brain Health | Dr. Perlmutter
44 research-tied claims examined: 1 contradicted 2 overstated 4 context 32 supported 5 unverified
2 Overstated
Interleukin-6 released by exercising muscle is a key trigger for the activation of AMP kinase (AMPK).
"We know, for example, that interleukin-6 released from muscles when they are exercised is one of the triggers, if not the most important trigger, for AMP kinase, and as such plays a really important role in regulating metabolism of glucose, insulin functionality, and fat utilization." (said at 0:25:00)
Muscle-derived interleukin-6 (IL-6) released during exercise contributes to the activation (phosphorylation) of AMP-activated protein kinase (AMPK) in skeletal muscle and adipose tissue, playing a role in regulating glucose uptake and fatty acid oxidation. However, describing IL-6 as "if not the most important trigger" for AMPK activation overstates its role. AMPK is primarily an intracellular energy sensor directly activated by changes in cellular energy state (elevated AMP/ATP and ADP/ATP ratios) and upstream kinases during muscle contraction. Studies in IL-6 knockout mice demonstrate that while basal AMPK activity and total exercise-induced AMPK activation are reduced without IL-6, significant exercise-induced AMPK activation still occurs in its absence, indicating that IL-6 contributes to but is not the sole or primary driver of AMPK activation.
- partial: AMPK activity is diminished in tissues of IL-6 knockout mice: the effect of exercise. (Biochemical and biophysical research communications 2004) · cited 288x in the literature
"The results indicate that IL-6 can activate AMPK in muscle and adipose tissue, and that this contributes to, but does not fully account for, the increase in AMPK activity in these tissues in response to exercise." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Interleukin-6 regulation of AMP-activated protein kinase. Potential role in the systemic r… (Diabetes 2006) · cited 187x in the literature
"Interleukin (IL)-6 is synthesized and released from skeletal muscle in large amounts during exercise, and in rodents, the resultant increase in its concentration correlates temporally with increases in AMPK activity in multiple tissues." (abstract, background)
pubmedfull study (doi) - supports: Muscles, exercise and obesity: skeletal muscle as a secretory organ. (Nature reviews. Endocrinology 2012) · cited 2881x in the literature
"BDNF and IL-6 are involved in AMPK-mediated fat oxidation." (abstract, results, passage verified)
pubmedfull study (doi)
Interleukin-6 is a strong biomarker and predictor for the development of depression and dementia.
"Now, interleukin-6 is one of the best predictors of conditions like depression and dementia. It is one of the most prototypical inflammatory molecules." (said at 0:20:29)
Interleukin-6 (IL-6) is a well-established pro-inflammatory cytokine associated with neuroinflammation, but describing it as 'one of the best predictors' or a 'strong biomarker' for the onset of depression and dementia overstates its predictive power. Systematic reviews and meta-analyses of prospective longitudinal studies show that while elevated IL-6 levels are statistically significantly associated with future depressive symptoms and cognitive decline, the effect sizes are modest (e.g., correlation coefficients r < 0.10 for depression; odds ratios around 1.34 for cognitive decline). IL-6 alone possesses limited individual diagnostic or predictive utility compared to established risk factors and disease-specific biomarkers (such as APOE ε4 status, amyloid-beta, and tau for Alzheimer's disease).
- partial: CRP, IL-6 and depression: a systematic review and meta-analysis of longitudinal studies. (Journal of affective disorders 2013) · cited 969x in the literature
"Raised inflammatory markers have a small but significant association with the subsequent development of depressive symptoms. This is a robust effect which remains significant after adjustment for age and a wide range of factors associated with risk for depression." (abstract, conclusions, passage verified)
pubmedfull study (doi) - partial: The longitudinal associations of inflammatory biomarkers and depression revisited: systema… (Molecular psychiatry 2021) · cited 358x in the literature
"Small, prospective associations of depression and inflammatory biomarkers are observed in both directions, particularly for IL-6; however, the strength and importance of this relationship is likely obscured by the heterogeneity in depression and profound study/methodological differences." (abstract, results, passage verified)
pubmedfull study (doi) - partial: Association of inflammation and cognition in the elderly: A systematic review and meta-ana… (Frontiers in aging neuroscience 2023) · cited 108x in the literature
"The data from longitudinal studies suggested that levels of IL-6 significantly increased the risk of cognitive decline [OR = 1.34, 95% CI (1.13, 1.56)]. However, intermediate levels of IL-6 had no significant effect on the final clinical endpoint [OR = 1.06, 95% CI (0.8, 1.32)]." (abstract, results, passage verified)
pubmedfull study (doi)
Unverified means no publication matching the claim was located; it does not prove the claim false. Spotted an error? See the corrections policy - disputes from the people quoted are prioritized.